MMPI-2 validity, clinical and content scales, and the Fake Bad Scale for personal injury litigants claiming idiopathic environmental intolerance

Journal of Psychosomatic Research

Volumn 62, Issue 1, 2007, Pages 61-72

  Staudenmayer, Herman ^a   Phillips, Scott ^b,c  

^a Center for Behavioral Medicine   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c NewFields   (United States)

Author keywords

Forensic assessment; Functional somatic syndromes; Idiopathic environmental intolerances; IEI; MMPI 2

Indexed keywords

ADULT; ARTICLE; DEFENSIVE BEHAVIOR; DEPRESSION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; FEMALE; FORENSIC PSYCHIATRY; HUMAN; HYPOCHONDRIASIS; HYSTERIA; IDIOPATHIC ENVIRONMENTAL INTOLERANCE; LAW SUIT; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MINNESOTA MULTIPHASIC PERSONALITY INVENTORY; PERSONALITY DISORDER;

ADULT; AGED; COMPENSATION AND REDRESS; DEFENSE MECHANISMS; DEPRESSION; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYPOCHONDRIASIS; HYSTERIA; MALE; MALINGERING; MIDDLE AGED; MMPI; MULTIPLE CHEMICAL SENSITIVITY; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; SICK ROLE; SOMATOFORM DISORDERS;

EID: 33845605506     PISSN: 00223999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2006.01.013     Document Type: Article

References (81)

1. International Programme on Chemical Safety/World Health Organization (IPCS/WHO). Conclusions and recommendations of a workshop on multiple chemical sensitivities (MCS). Regul Toxicol Pharmacol 24 (1996) S188-S189
2. Cullen M. The worker with multiple chemical sensitivities: an overview. Occup Med 2 (1987) 655-662
3. Caccappolo-van Vliet E., Kelly-McNeil K., Natelson B., Kipen H., and Fiedler N. Anxiety sensitivity and depression in multiple chemical sensitivities and asthma. J Occup Environ Med 44 (2002) 890-901
4. Staudenmayer H., Binkley K., Leznoff A., and Phillips S. Idiopathic Environmental Intolerance: Part 1. A causation analysis applying Bradford Hill's criteria to the toxicogenic theory. Toxicol Rev 22 (2003) 235-246
5. Staudenmayer H., Binkley K., Leznoff A., and Phillips S. Idiopathic Environmental Intolerance: Part 2. A causation analysis applying Bradford Hill's criteria to the psychogenic theory. Toxicol Rev 22 (2003) 247-261
6. American Academy of Allergy Asthma and Immunology. Board of Directors Position statement: Idiopathic Environmental Intolerances. J Allergy Clin Immunol 103 (1999) 36-40
7. American College of Occupational and Environmental Medicine. Multiple chemical sensitivities: idiopathic environmental intolerance. Position statement. ACOEM Rep (1999) 1-3
8. American Academy of Clinical Toxicology, Board of Trustees minutes, March 29, 2000.
9. Rea W. Chemical sensitivity: vol. 1. Principles and mechanisms (1992), Lewis Publishers/CRC Press, Boca Raton (Fla)
10. Ashford N., and Miller C. Chemical exposures: low levels and high stakes. 2nd ed (1998), Van Nostrand Reinhold, New York
11. American Medical Association. Council on Scientific Affairs Report: clinical ecology. JAMA 268 (1992) 3465-3467
12. American College of Physicians. Position paper: clinical ecology. Ann Intern Med 111 (1989) 168-178
13. Royal College of Physicians. Allergy, conventional and alternative concepts. Report by the Committee on Clinical Immunology and Allergy (1992), Royal College of Physicians, London
14. International Society of Regulatory Toxicology and Pharmacology (ISRTP). Report of the Board. Regul Toxicol Pharmacol 18 (1993) 79
15. Hammond E. Some preliminary findings on physical complaints from a prospective study of 1,064,004 men and women. Am J Public Health 54 (1964) 11-23
16. Eriksen H., and Ursin H. Subjective health complaints, sensitization, and sustained cognitive activation (stress). J Psychosom Res 56 (2004) 445-448
17. Hausteiner C., Bornschein S., Bickel H., et al. Psychiatric morbidity and low self-attentiveness in patients with environmental illness. J Nerv Ment Dis 191 (2003) 50-55
18. Simon G., VonKorff M., Piccinelli M., et al. An international study of the relation between somatic symptoms and depression. N Engl J Med 341 (1999) 1329-1335
19. Simon D., Daniell W., Stockbridge H., Claypoole K., and Rosenstock L. Immunologic, psychological, and neuropsychological factors in multiple chemical sensitivity: a controlled study. Ann Intern Med 19 (1993) 97-103
20. Bolla K. Neurobehavioral performance in multiple chemical sensitivities. Regul Toxicol Pharmacol 24 (1996) S52-S54
21. Fiedler N., Kipen H., DeLuca J., Kelly-McNeil K., and Natelson B. A controlled comparison of multiple chemical sensitivity and chronic fatigue syndrome. Psychosom Med 58 (1996) 38-49
22. Brown-DeGagne A., McGlone J., and Santor D. Somatic complaints disproportionately contribute to Beck Depression Inventory estimates of depression severity in individuals with multiple chemical sensitivity. J Occup Environ Med 40 (1998) 862-869
23. Bolla K. Use of neuropsychological testing in idiopathic environmental intolerance. Occup Med 15 (2000) 617-625
24. Nimnuan C., Hotopf M., and Wessely S. Medically unexplained symptoms: an epidemiological study in seven specialties. J Psychosom Res 51 (2001) 361-367
25. Staudenmayer H. Psychological treatment of psychogenic idiopathic environmental intolerance. Occup Med 15 (2000) 627-646
26. Bornschein S., Forstl H., and Zilker T. Idiopathic Environmental Intolerances (formerly multiple chemical sensitivity) psychiatric perspectives. J Intern Med 250 (2001) 309-321
27. Ford C. Somatization and fashionable diagnoses: illness as a way of life. Scan J Work Environ Health 23 Suppl 3 (1997) 7-16
28. Barsky A., and Borus J. Somatization and medicalization in the era of managed care. JAMA 274 (1995) 1931-1934
29. Shorter E. From paralysis to fatigue: a history of psychosomatic illness in the modern era (1992), Free Press/Macmillan, New York
30. Shorter E. Multiple chemical sensitivity: pseudodisease in historical perspective. Scand J Work Environ Health 23 Suppl 3 (1997) 35-42
31. Staudenmayer H. Environmental illness: myth and reality (1999), CRC/Lewis Publishers, Boca Raton
32. Staudenmayer H. Idiopathic Environmental Intolerances (IEI): myth and reality. Toxicol Lett 120 (2001) 333-342
33. Hathaway S., and McKinley J. A multiphasic personality schedule (Minnesota): 1. Construction of the schedule. J Psychol 10 (1940) 249-254
34. Butcher J., Dahlstrom W., Graham J., et al. Minnesota Multiphasic Personality Inventory (MMPI-2) (1989), University of Minnesota Press, Minneapolis (Minn)
35. Pope K., Butcher J., and Seelen J. The MMPI, MMPI-2, & MMPI-A in court. 2nd ed (2000), American Psychological Association, Washington (DC)
36. Graham J. MMPI-2 Assessing personality and psychopathology. 3rd ed (2000), Oxford University Press, New York
37. Butcher J., and Williams C. Essentials of MMPI-2 and MMPI-A interpretation. 2nd ed (2000), University of Minnesota Press, Minneapolis
38. Lees-Haley P., Iverson G., Lange R., Fox D., and Allen L. Malingering in forensic neuropsychology: Daubert and the MMPI-2. J Forensic Neuropsychol 3 (2003) 167-203
39. Lees-Haley P., English L., and Glenn W. A fake bad scale on the MMPI-2 for personal injury claimants. Psychol Rep 68 (1991) 203-210
40. Lees-Haley P. Efficacy of MMPI-2 validity scales and MCMI-II modifier scales for detecting spurious PTSD claims: F, F-K, Fake Bad Scale, Ego Strength, subtle-obvious subscales, DIS and DEB. J Clin Psychol 48 (1992) 681-689
41. Greiffenstein M., Baker W., Axelrod B., Peck E., and Gervais R. The Fake Bad Scale and MMPI-2 F-family in detection of implausible psychological trauma claims. Clin Neuropsychol 18 (2004) 573-590
42. Posthuma A., and Harper J. Comparison of MMPI-2 responses of child custody and personal injury litigants. Prof Psychol Res Pract 29 (1998) 437-443
43. Tsushima W., and Tsushima V. Comparison of the Fake Bad Scale and other MMPI-2 validity scales with personal injury litigants. Assessment 8 (2001) 205-212
44. Greiffenstein M., Baker W., Gola T., Donders J., and Miller L. The Fake Bad Scale in atypical and severe closed head injury litigants. J Clin Psychol 58 (2002) 1591-1600
45. Ross S., Millis S., Krukowski R., Putnam S., and Adams K. Detecting incomplete effort on the MMPI-2: an examination of the Fake-Bad Scale in mild head injury. J Clin Exp Neuropsychol 26 (2004) 115-124
46. Larrabee G. Exaggerated MMPI-2 symptom report in personal injury litigants with malingered neurocognitive deficit. Arch Clin Neuropsychol 18 (2003) 673-686
47. Larrabee G. Detection of symptom exaggeration with the MMPI-2 in litigants with malingered neurocognitive dysfunction. Clin Neuropsychol 17 (2003) 54-68
48. Larrabee G. Detection of malingering using atypical performance patterns on standard neuropsychological tests. Clin Neuropsychol 17 (2003) 410-425
49. Nelson N., Sweet J., and Demakis G. Meta-analysis of the MMPI-2 Fake Bad Scale: utility in forensic practice. Clin Neuropsychol 20 (2006) 39-58
50. Butcher J., Graham J., Ben-Porath Y., et al. MMPI-2 (Minnesota Multiphasic Personality Inventory-2): manual for administration and scoring (2001), University of Minnesota Press, Minneapolis
51. P. Psychol Assess 7 (1995) 424-431
52. Greene R. Assessment of malingering and defensiveness on multiscale inventories. In: Rogers R. (Ed). Clinical assessment of malingering and deception. 2nd ed (1997), Guilford Press, New York 169-207
53. Lees-Haley P. MMPI-2 base rates for 492 personal injury plaintiffs: implications and challenges for forensic assessment. J Clin Psychol 53 (1997) 745-755
54. Lanyon R. Dimensions of self-serving misrepresentation in forensic assessment. J Pers Assess 76 (2001) 169-179
55. Leavitt F., and Katz R. Is the MMPI invalid for assessing psychological disturbance in pain related organic conditions?. J Rheumatol 16 (1989) 521-526
56. Keller L., and Butcher J. Use of the MMPI-2 with chronic pain patients (1991), University of Minnesota Press, Minneapolis
57. Winfield J. Pain in fibromyalgia. Rheumatol Clin North Am 25 (1999) 55-79
58. Payne T., Leavitt F., Garron D., et al. Fibrositis and psychologic disturbance. Arthritis Rheum 25 (1982) 213-217
59. Ahles T., Yunus M., Riley S., et al. Psychological factors associated with primary fibromyalgia syndrome. Arthritis Rheum 27 (1984) 1101-1106
60. Wolfe F., Cathey M., Kleinheksel S., et al. Psychological status in primary fibrositis and fibrositis associated with rheumatoid arthritis. J Rheumatol 11 (1984) 500-506
61. Thompson W. Symptomatic perceptions of the irritable bowel syndrome. Gastrointest Clin N Am 20 (1991) 235-247
62. Drossman D., McKee D., Sandler R., et al. Psychosocial factors in the irritable bowel syndrome: a multivariate study of patients and non-patients with irritable bowel syndrome. Gastroenterology 95 (1988) 701-708
63. Blanchard E., Keefer L., Galovski T., et al. Gender differences in psychological distress among patients with irritable bowel syndrome. J Psychosom Res 50 (2001) 271-275
64. Holmes G., Kaplan J., Stewart J., Hunt B., Pinsky P., and Schonberger L. A cluster of patients with a chronic mononucleosis-like syndrome: is Epstein-Barr virus the cause?. JAMA 257 (1987) 2297-2302
65. Kruesi M., Dale J., and Straus S. Psychiatric diagnoses in patients who have chronic fatigue syndrome. J Clin Psychiatry 50 (1989) 53-56
66. Stricklin A., Sewell M., and Austad C. Objective measurement of personality variables in epidemic neuromyasthenia patients. S Afr Med J 77 (1990) 31-34
67. Blakely A., Howard R., Sosich R., Murdoch J., Menkes D., and Spears G. Psychiatric symptoms, personality and ways of coping in chronic fatigue syndrome. Psychol Med 21 (1991) 347-362
68. Schmaling K., and Jones J. MMPI profiles of patients with chronic fatigue syndrome. J Psychosom Res 40 (1996) 67-74
69. World Health Organization. Mental disorders: glossary and guide to their classification in accordance with the 9th revision of the International Classification of Diseases (1978), World Health Organization, Geneva
70. American Academy of Neurology. Report of the Therapeutics and Technology Assessment Subcommittee: assessment of neuropsychological testing in adults. Neurology 47 (1996) 592-599
71. Binder L., and Willis S. Assessment of motivation after financially compensable minor head trauma. Psychol Assess 3 (1991) 175-181
72. Binder L., and Rohling M. Money matters: a meta-analytic review of the effects of financial incentives on recovery after closed head injury. Am J Psychiatry 153 (1996) 7-10
73. Youngjohn J., Burrows L., and Erdal K. Brain damage or compensation neurosis? The controversial post-concussion syndrome. Clin Neuropsychol 9 (1995) 112-123
74. Youngjohn J., Davis D., and Wolf I. Head injury and MMPI-2: paradoxical severity effects and the influence of litigation. Psychol Assess 9 (1997) 177-184
75. Deary I. A taxonomy of medically unexplained symptoms. J Psychosom Res 47 (1999) 51-59
76. Nimnuan C., Rabe-Hesketh S., Wessely S., and Hotopf M. How many functional somatic syndromes?. J Psychosom Res 51 (2001) 549-557
77. Wessely S. Chronic fatigue syndrome: a 20th century illness. Scand J Work Environ Health 23 Suppl 3 (1997) 17-34
78. Ursin H., and Eriksen H. The cognitive activation theory of stress. Psychoneuroendocrinology 29 (2004) 567-592
79. McKenna P. Disorders with overvalued ideas. Br J Psychiatry 145 (1984) 579-585
80. Hubert P. Galileo's revenge: junk science in the court room (1991), Basic Books, New York
81. Terr A. Environmental illness: a clinical review of 50 cases. Arch Intern Med 146 (1986) 145